News & Updates

Eye response to prior DEX implant tied to response after switching to fluocinolone acetonide

03 Dec 2021

Visual and anatomic responses to a previous dexamethasone (DEX) implant predicts patient response after switching to fluocinolone acetonide (FAc) implant, a recent study has found.

Eye response to prior DEX implant tied to response after switching to fluocinolone acetonide

03 Dec 2021

TheraPearl equals Blephasteam at improving meibomian gland dysfunction symptoms

24 Nov 2021 by

Blephasteam and TheraPearl, two warm compress medical devices worn over the eyes, achieve comparable efficacy in treating mild to moderate meibomian gland dysfunction (MGD), according to a recent study.

TheraPearl equals Blephasteam at improving meibomian gland dysfunction symptoms

24 Nov 2021

Hyperglycaemic infants at risk of retinopathy of prematurity

23 Nov 2021

Infants with hyperglycaemia are at an increased risk of having retinopathy of prematurity (ROP), a recent study has found. Meanwhile, no such effect was observed for serum levels of glycated albumin (GlyA).

Hyperglycaemic infants at risk of retinopathy of prematurity

23 Nov 2021

$Tocilizumab outperforms anti-TNF-α in refractory uveitic macular edema$

Tocilizumab outperforms anti-TNF-α in refractory uveitic macular edema

22 Nov 2021

Patients with refractory uveitic macular edema are more likely to achieve complete response with tocilizumab than with antitumour necrosis factor alpha (anti-TNF-α) drugs, as reported in a study.

Tocilizumab outperforms anti-TNF-α in refractory uveitic macular edema

22 Nov 2021

Cataract surgery delivers no long-term risk of age-related macular degeneration

20 Nov 2021

Cataract surgery is safe and does not confer an increased risk of developing late age-related macular degeneration over 10 years of follow-up, according to a study.

Cataract surgery delivers no long-term risk of age-related macular degeneration

20 Nov 2021

Retinopathy of prematurity outcomes better with anti-VEGF than primary laser treatment

17 Nov 2021

Children with retinopathy of prematurity (ROP) who receive antivascular endothelial growth factor (anti-VEGF) therapy fare better than their counterparts who undergo primary laser treatment, a study has found.

Retinopathy of prematurity outcomes better with anti-VEGF than primary laser treatment

17 Nov 2021

Nasal spray eases signs, symptoms of dry eye disease

15 Nov 2021 by

The varenicline-containing nasal spray OC-01 appears beneficial in the treatment of dry eye disease, producing improvements in natural tear film production and patient-reported symptoms with a tolerable safety profile, as shown in the phase III trial ONSET-2.

Nasal spray eases signs, symptoms of dry eye disease

15 Nov 2021

Childhood myopia boom during COVID-19 pandemic a potential public health crisis

15 Nov 2021 by

Unprecedented quarantine and social distancing measures implemented during the coronavirus disease 2019 (COVID-19) pandemic have resulted in a “myopia boom” in school-aged children in Hong Kong, according to results of a population-based study by the Chinese University of Hong Kong (CUHK).

Childhood myopia boom during COVID-19 pandemic a potential public health crisis

15 Nov 2021

Automatic retinal image analysis identifies diabetes early with high sensitivity

15 Nov 2021 by

Screening of undiagnosed diabetes can be performed effectively with an automatic retinal image analysis (ARIA) technology developed by researchers at the Chinese University of Hong Kong (CUHK), instead of a finger-prink test.

Automatic retinal image analysis identifies diabetes early with high sensitivity

15 Nov 2021

Original New Drug Application Approvals by US FDA (16-31 October 2021)

07 Nov 2021

New drug applications approved by US FDA as of 16-31 October 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 October 2021)

07 Nov 2021

News & Updates

Filter by Specialty:

Specialty:

Eye response to prior DEX implant tied to response after switching to fluocinolone acetonide

Eye response to prior DEX implant tied to response after switching to fluocinolone acetonide

TheraPearl equals Blephasteam at improving meibomian gland dysfunction symptoms

TheraPearl equals Blephasteam at improving meibomian gland dysfunction symptoms

Hyperglycaemic infants at risk of retinopathy of prematurity

Hyperglycaemic infants at risk of retinopathy of prematurity

Tocilizumab outperforms anti-TNF-α in refractory uveitic macular edema

Tocilizumab outperforms anti-TNF-α in refractory uveitic macular edema

Cataract surgery delivers no long-term risk of age-related macular degeneration

Cataract surgery delivers no long-term risk of age-related macular degeneration

Retinopathy of prematurity outcomes better with anti-VEGF than primary laser treatment

Retinopathy of prematurity outcomes better with anti-VEGF than primary laser treatment

Nasal spray eases signs, symptoms of dry eye disease

Nasal spray eases signs, symptoms of dry eye disease

Childhood myopia boom during COVID-19 pandemic a potential public health crisis

Childhood myopia boom during COVID-19 pandemic a potential public health crisis

Automatic retinal image analysis identifies diabetes early with high sensitivity

Automatic retinal image analysis identifies diabetes early with high sensitivity

Original New Drug Application Approvals by US FDA (16-31 October 2021)

Original New Drug Application Approvals by US FDA (16-31 October 2021)